Effect of antibiotics on biofilm inhibition and induction measured by real-time cell analysis

Journal of Applied Microbiology

Volumn 122, Issue 3, 2017, Pages 640-650

  Ferrer, M D ^a   Rodriguez, J C ^b   Alvarez L ^b   Artacho, A ^a   Royo, G ^b   Mira, A ^a  

^a Gerencia FISABIO   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

Author keywords

antibiotic resistance; biofilm; medical implants; MIC; RTCA; Staphylococcus

Indexed keywords

ANTIBIOTICS; BACTERIA; ELECTRIC IMPEDANCE MEASUREMENT; IMPLANTS (SURGICAL);

ANTIBIOTICS RESISTANCE; BIOFILM GROWTH; BIOFILM INHIBITIONS; CELL ANALYSIS; IMPEDANCE MEASUREMENT; MEDICAL IMPLANTS; MIC; REAL- TIME; RTCA; STAPHYLOCOCCUS;

BIOFILMS;

ANTIBIOTIC AGENT; CEFOTAXIME; CLARITHROMYCIN; CLOXACILLIN; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MOXIFLOXACIN; PROTEINASE; RIFAMPICIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; BIOFILM; ELECTRODE; GOLD; INHIBITION; MEDICINAL PLANT; REAL TIME;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BACTERIUM MUTANT; BIOFILM; CELL ASSAY; CELL COUNT; CELL GROWTH; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRODE; ELECTRONIC IMPEDANCE TECHNOLOGY; GOLD ELECTRODE; MICROTITER PLATE ASSAY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PHYSIOLOGY; PROCEDURES;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

ANTI-BACTERIAL AGENTS; BIOFILMS; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 85013680727     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13368     Document Type: Article

References (36)

1. Atienza, J.M., Zhu, J., Wang, X., Xu, X. and Abassi, Y. (2005) Dynamic monitoring of cell adhesion and spreading on microelectronic sensor arrays. J Biomol Screen 10, 795–805.
2. Boix-Amorós, A., Collado, M.C. and Mira, A. (2016) Relationship between milk microbiota, bacterial load, macronutrients, and human cells during lactation. Front Microbiol 7, 492.
3. Boles, B.R. and Horswill, A.R. (2011) Staphylococcal biofilm disassembly. Trends Microbiol 19, 449–455.
4. Bruchmann, J., Sachsenheimer, K., Rapp, B.E. and Schwartz, T. (2015) Multi-channel microfluidic biosensor platform applied for online monitoring and screening of biofilm formation and activity. PLoS ONE 10, e0117300.
5. Calcagno, V. (2013) glmulti: Model selection and multimodel inference made easy. R package version 1.0.7. Available at: http://CRAN.R-project.org/package=glmulti.
6. Ceri, H., Olson, M.E., Stremick, C., Read, R.R., Morck, D. and Buret, A. (1999) The Calgary Biofilm Device: new technology for rapid determination of antibiotic susceptibilities of bacterial biofilms. J Clin Microbiol 37, 1771–1776.
7. Chabowski, K., Junka, A.F., Szymczyk, P., Piasecki, T., Sierakowski, A., Mączynska, B. and Nitsch, K. (2015) The application of impedance microsensors for real-time analysis of Pseudomonas aeruginosa biofilm formation. Pol J Microbiol 64, 115–120.
8. Cihalova, K., Chudobova, D., Michalek, P., Moulick, A., Guran, R., Kopel, P., Adam, V. and Kizek, R. (2015) Staphylococcus aureus and MRSA growth and biofilm formation after treatment with antibiotics and SeNPs. J Mol Sci 16, 24656–24672.
9. Clinical and Laboratory Standards Institute (2011) Performance Standards for Antimicrobial Susceptibility Testing: Twenty-First Informational Supplement M100–S21. Wayne, PA, USA: Clinical and Laboratory Standards Institute.
10. Coenye, T. and Nelis, H.J. (2010) In vitro and in vivo model systems to study microbial biofilm formation. J Microbiol Methods 83, 89–105.
11. Cramton, S.E., Ulrich, M., Götz, F. and Döring, G. (2001) Anaerobic conditions induce expression of polysaccharide intercellular adhesin in Staphylococcus aureus and Staphylococcus epidermidis. Infect Immun 69, 4079–4085.
12. Cucarella, C., Solano, C., Valle, J., Amorena, B., Lasa, I. and Penadés, J.R. (2001) Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J Bacteriol 183, 2888–2896.
13. Donlan, R.M. (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8, 881–890.
14. Fey, P.D. (2010) Modality of bacterial growth presents unique targets: how do we treat biofilm-mediated infections? Curr Opin Microbiol 13, 610–615.
15. Hall-Stoodley, L. and Stoodley, P. (2009) Evolving concepts in biofilm infections. Cell Microbiol 11, 1034–1043.
16. Hamilton, M. (Ed.) (2003) The Biofilm Laboratory: Step-by-Step Protocols for Experimental Design, Analysis, and Data Interpretation. Cytergy.
17. Jhajharia, K., Parolia, A., Shetty, K.V. and Mehta, L.K. (2015) Biofilm in endodontics: a review. J Int Soc Prev Community Dent 5, 1–12.
18. Junka, A.F., Janczura, A., Smutnicka, D., Maczynska, B., Secewicz, A., Nowicka, J., Bartoszewicz, M. and Gosciniak, G. (2012) Use of the real time xCelligence system for purposes of medical microbiology. Pol J Microbiol 61, 191–197.
19. Kaplan, J.B. (2009) Therapeutic potential of biofilm-dispersing enzymes. Int J Artif Organs 32, 545–554.
20. Kaplan, J.B. (2011) Antibiotic-induced biofilm formation. Int J Artif Organs 34, 737–751.
21. Ke, N., Wang, X., Xu, X. and Abassi, Y.A. (2001) The xCELLigence system for real-time and label-free monitoring of cell viability. Methods Mol Biol 740, 33–43.
22. Kumar, S.S. and Rao, T.S. (2013) Dispersal of Bap-mediated Staphylococcus aureus biofilm by proteinase K. J Antibiot 66, 55–60.
23. López, D., Vlamakis, H. and Kolter, R. (2010) Biofilms. Cold Spring Harb Perspect Biol 2, a000398.
24. National Committee for Clinical Laboratory Standards (2009) Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically – Eighth Edition: Approved Standard M7–A8. Wayne, PA, USA: NCCLS.
25. O'Gara, J.P. (2007) Ica and beyond: biofilm mechanisms and regulation in Staphylococcus epidermidis and Staphylococcus aureus. FEMS Microbiol Lett 270, 179–188.
26. Otto, M. (2008) Staphylococcal biofilms. Curr Top Microbiol Immunol 322, 207–228.
27. Parsek, M.R. and Singh, P.K. (2003) Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol 57, 677–701.
28. Qin, Z., Yang, X., Yang, L., Jiang, J., Ou, Y., Molin, S. and Qu, D. (2007) Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates. J Med Microbiol 56, 83–93.
29. Ribeiro, S.M., Felício, M.R., Boas, E.V., Gonçalves, S., Costa, F.F., Samy, R.P., Santos, N.C. and Franco, O.L. (2016) New frontiers for anti-biofilm drug development. Pharmacol Ther 160, 133–144.
30. Saginur, R., Stdenis, M., Ferris, W., Aaron, S.D., Chan, F., Lee, C. and Ramotar, K. (2006) Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob Agents Chemother 50, 55–61.
31. Santos, S.R. and Ochman, H. (2004) Identification and phylogenetic sorting of bacterial lineages with universally conserved genes and proteins. Environ Microbiol 6, 754–759.
32. Solly, K., Wang, X., Xu, X., Strulovici, B. and Zheng, W. (2004) Application of real-time cell electronic sensing (RT-CES) technology to cell-based assays. Assay Drug Dev Technol 2, 363–372.
33. Tormo, M.A., Martí, M.A., Valle, J., Manna, A.C., Cheung, A.L., Lasa, I. and Penadés, J.R. (2005) SarA is an essential positive regulator of Staphylococcus epidermidis biofilm development. J Bacteriol 187, 2348–2356.
34. Toté, K., Vanden, B.D., Maes, L. and Cos, P. (2008) A new colorimetric microtitre model for the detection of Staphylococcus aureus biofilms. Lett Appl Microbiol 46, 249–254.
35. Valle, J., Toledo-Arana, A., Berasain, C., Ghigo, J.M., Amorena, B., Penadés, J.R. and Lasa, I. (2003) SarA and not sigmaB is essential for biofilm development by Staphylococcus aureus. Mol Microbiol 48, 1075–1087.
36. Wang, Q., Sun, F.J., Liu, Y., Xiong, L.R., Xie, L.L. and Xia, P.Y. (2010) Enhancement of biofilm formation by subinhibitory concentrations of macrolides in icaADBC-positive and -negative clinical isolates of Staphylococcus epidermidis. Antimicrob Agents Chemother 54, 2707–2711.